Skip to main content
Clinical Trials/DRKS00024175
DRKS00024175
Recruiting
N/A

A prospective observational study to evaluate biomarkers and disease mechanisms in patients with moderate to severe atopic dermatitis with systemic therapy - ImmUniverse AD

Department of Dermatology and AllergyUniversity Hospital Schleswig-Holstein (UKSH)0 sites300 target enrollmentFebruary 3, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Dermatology and AllergyUniversity Hospital Schleswig-Holstein (UKSH)
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Dermatology and AllergyUniversity Hospital Schleswig-Holstein (UKSH)

Eligibility Criteria

Inclusion Criteria

  • 1\) Written informed consent from the study participant prior to performing any study\-related activities.
  • 2\) Age \= 18 years at the time of study entry.
  • 3\) Clinically diagnosed atopic dermatitis.
  • 4\) Initiation of systemic therapy for atopic dermatitis by the treating physician as part of routine care
  • 5\) Study participant agrees and, in the judgment of study personnel, is able to comply with the study protocol for the duration of the study

Exclusion Criteria

  • 1\) Study participant is not capable of consenting to study participation or adhering to the study protocol.
  • 2\) Tendency to keloid/hypertrophic scarring and/or known wound healing disorder.
  • 3\) Tattooing and/or skin lesions due to a dermatosis in the puncture area not investigated in this study
  • 4\) Needle phobia
  • 5\) Pregnancy
  • 6\) Liver/biliary tract disease present at the time of the study and judged unstable by the study physician, manifested by ascites, encephalopathy, coagulopathy, hypoalbuminemia, esophageal/gastric varices, persistent jaundice, and/or liver cir\-rhosis
  • 7\) Known allergy and/or hypersensitivity to the materials used.
  • 8\) Any reason that, in the opinion of the study physician, may prevent safe participation of the study participant.

Outcomes

Primary Outcomes

Not specified

Similar Trials